FTC Requires Hikma to Sell Two Drugs as Condition of Baxter Healthcare Acquisition
Date
The Federal Trade Commission will require Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to...